Metraipolis › archive › dc_fb511d66c173
Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results… — Europe PMC PMID:41641897
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41641897
- DOI
- 10.1002/cpdd.70031
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T08:17:50.635Z
- SHA-256 of the archived text
6f8c2e3c79755af29376566e64929b76d64d19c0285fcdeccfb42a1164921975- Stable URL of this page
https://metraipolis.com/documento/dc_fb511d66c173
How to cite
Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results… — Europe PMC PMID:41641897 — Europe PMC (en), https://europepmc.org/article/MED/41641897 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb511d66c173 (Metraipolis archive dc_fb511d66c173, sha256 6f8c2e3c79755af29376566e64929b76d64d19c0285fcdeccfb42a1164921975)
BibTeX
@misc{dcfb511d66c173,
title = {Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results… — Europe PMC PMID:41641897},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41641897},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb511d66c173; sha256 6f8c2e3c79755af29376566e64929b76d64d19c0285fcdeccfb42a1164921975},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41641897. Agents can read the archived copy with the MCP tool read_document.